patient compliance
Should Generics be 'Trade Dressed' to Boost Patient Compliance?
August 02 by Pharma IQIs it fair to say that providing patients with generics that look different from their branded counterparts has a negative impact on health outcomes? Would a uniform 'dress code' really be a...
Sharpen up on Patient Self-Management Approaches
May 31 by Helen WinsorSoren Skovlund, Director of Patient Research, Advocacy and Support at NovoNordisk, joins Helen Winsor from Pharma IQ, to discuss best practice approaches to patient education and self management....
30% of Diabetes Patients Admit Skipping Insulin Injections
May 19 by Helen WinsorPatricia DeCock, Medical Affairs Manager Diabetes at Sanofi Aventis, joins Pharma IQ to discuss the problems associated with patient adherence to treatment of Type 1 and 2 diabetes, in paediatrics,...
Stumbling Blocks for Patient Compliance in Parkinson’s Disease Treatment
May 12 by Helen WinsorNicolas Favre, International Brand Manager, Azilect at Lundbeck, joins Pharma IQ to discuss the commonly experienced patient adherence challenges for Parkinson’s Disease sufferers. He also...
Delivering Patient Compliance Through User Focused Development of Delivery Systems
December 20 by Andrea CharlesTim Chesworth, Team Manager - Packaging & Devices at AstraZeneca, joins Andrea Charles from Pharma IQ, to speak about delivering patient compliance through user focused developme...
Patient Empowerment and Compliance:The Role of Direct to Consumer (DTC) Advertising
May 26 by James HarrisIt is a given fact that more households are wired to the internet and individuals are introduced to an onslaught of information for various venues. The internet is a tool that allows individua...
Novo Nordisk's Søren Skovlund Speaks to Pharma IQ about Best Practice Approaches to Patient Education and Self-Management
May 15 by Soren SkovlundSøren Skovlund is director of global patient research, advocacy and support in Novo Nordisk and oversees the global DAWN (Diabetes Attitudes Wishes & Needs) study led by Novo Nordisk. In...